Who makes Proctocella?

Proctocella is developed by University of Roma La Sapienza.

What development phase is Proctocella in?

Proctocella is FDA-approved (marketed).

Last reviewed 2026-04-19 · How we verify

Proctocella

University of Roma La Sapienza · FDA-approved active Small molecule

At a glance

Generic name	Proctocella
Sponsor	University of Roma La Sapienza
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Pain and Bleeding in Subjects With Acute Anal Fissure: Comparative Evaluation of Three Treatments (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Proctocella CI brief — competitive landscape report
Proctocella updates RSS · CI watch RSS
University of Roma La Sapienza portfolio CI